Statistics
Publications
3
Citations
437
H-Index
3
Active since
2003
Michelle Ashe is an author at Cornell University specializing in therapeutic monoclonal antibodies, cancer immunology, and immunotherapy.
Publications per year
2003–2005
3
3
Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma
John P. Leonard, Morton Coleman, Jamie Ketas et al. · Clinical Cancer Research · 2004 · 227 citations
Pharmacy, Hematology, Pharmacology +17
Epratuzumab: targeting B-cell malignancies through CD22.
Morton Coleman, David M. Goldenberg, Abby B. Siegel et al. · PubMed · 2003 · 47 citations
Medicine, Oncology, Pharmacology +17
1–3 of 3